Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) (CAPTUR)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03297606 |
|
Recruitment Status :
Recruiting
First Posted : September 29, 2017
Last Update Posted : April 29, 2024
|
Sponsor:
Canadian Cancer Trials Group
Collaborators:
AstraZeneca
Bristol-Myers Squibb
Hoffmann-La Roche
Pfizer
Seagen Inc.
Information provided by (Responsible Party):
Canadian Cancer Trials Group
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | January 31, 2026 |
| Estimated Study Completion Date : | January 31, 2027 |